These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4441467)

  • 1. Factor VII in an industrial population.
    Brozovic M; Stirling Y; Harricks C; North WR; Meade TW
    Br J Haematol; 1974 Nov; 28(3):381-91. PubMed ID: 4441467
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of a coagulation assay determining the activity state of factor VII in plasma.
    van Deijk WA; van Dam-Mieras MC; Muller AD; Hemker HC
    Haemostasis; 1983; 13(3):192-7. PubMed ID: 6604003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An epidemiological study of the haemostatic and other effects of oral contraceptives.
    Meade TW; Brozović M; Chakrabarth R; Howarth DJ; North WR; Stirling Y
    Br J Haematol; 1976 Nov; 34(3):353-64. PubMed ID: 990177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestational agents and blood coagulation. VI. Relationship of ABO blood types to changes induced by oral contraceptives.
    Lillie MA; Mink IB
    Am J Obstet Gynecol; 1974 Jun; 119(3):406-10. PubMed ID: 4827381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of factor VII on the assay of factor VIII by the one stage method using wettable surface.
    Altman R; Rouvier J; Reussi C
    Thromb Diath Haemorrh; 1972 Dec; 28(3):457-63. PubMed ID: 4675266
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause.
    Balleisen L; Bailey J; Epping PH; Schulte H; van de Loo J
    Thromb Haemost; 1985 Aug; 54(2):475-9. PubMed ID: 3936217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclical changes in coagulation factors associated with the use of progestational agents.
    McGrath KM; Castaldi PA
    Haemostasis; 1975; 4(2):73-80. PubMed ID: 1205338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activity state of factor VII in plasma: two pathways for the cold promoted activation of factor VII.
    Muller AD; van Deijk WA; Devilée PP; van Dam-Mieras MC; Hemker HC
    Br J Haematol; 1986 Feb; 62(2):367-77. PubMed ID: 3484966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of circulating tissue factor and factor VII in a normal population.
    Albrecht S; Kotzsch M; Siegert G; Luther T; Grossmann H; Grosser M; Müller M
    Thromb Haemost; 1996 May; 75(5):772-7. PubMed ID: 8725722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VII clotting assay: influence of different thromboplastins and factor VII-deficient plasmas. CISMEL Study Group.
    Poggio M; Tripodi A; Mariani G; Mannucci PM
    Thromb Haemost; 1991 Feb; 65(2):160-4. PubMed ID: 2053102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progestational agents and blood coagulation. V. Changes induced by sequential oral contraceptive therapy.
    Mink IB; Courey NG; Niswander KR; Moore RH; Lillie MA; Ambrus JL
    Am J Obstet Gynecol; 1974 Jun; 119(3):401-5. PubMed ID: 4275088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of oral contraceptives and exercise on hemostatic and fibrinolytic mechanisms in trained women.
    Huisveld IA; Hospers JE; Bernink MJ; Erich WB; Bouma BN
    Int J Sports Med; 1983 May; 4(2):97-103. PubMed ID: 6874180
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization and comparison of immune-depleted and hereditary factor-VII-deficient plasmas as substrate plasmas for factor VII assays.
    Brandt JT; Triplett DA; Fair DS
    Am J Clin Pathol; 1986 May; 85(5):583-9. PubMed ID: 3518398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Haut-Doubs FVII variant depending on species-derived-thromboplastin reagent (F7:p.Arg337His).
    Mourey G; Tachon G; Pellequer JL; Zawadzki C; Trossaërt M; Bertrand MA; Schved JF; Giansily-Blaizot M
    Haemophilia; 2014 Jul; 20(4):e347-9. PubMed ID: 24805822
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor VII and ischaemic heart disease: epidemiological evidence.
    Meade TW
    Haemostasis; 1983; 13(3):178-85. PubMed ID: 6350123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a congenital defect of factor VII in a colony of beagle dogs: the clinical use of the plasma.
    Poller L; Thomson JM; Sear CH; Thomas W
    J Clin Pathol; 1971 Oct; 24(7):626-32. PubMed ID: 5165796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory control of oral anticoagulants. Definition of therapeutic range in terms of different thromboplastin preparations.
    Loeliger EA; Meuwisse-Braun JB; Muis H; Buitendijk FJ; Veltkamp JJ; Hemker HC
    Thromb Diath Haemorrh; 1970 Jun; 23(3):569-84. PubMed ID: 5432194
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypercoagulability associated with chronic ulcerative colitis: changes in blood coagulation factors.
    Lee LC; Spittell JA; Sauer WG; Owen CA; Thompson JH
    Gastroenterology; 1968 Jan; 54(1):76-85. PubMed ID: 5638294
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of coagulation factors (II-VII-X) and kaolin partial thromboplastin time by the LKB 8600 Reaction Rate Analyser.
    Hjorth B; Kjaersgaard E
    Scand J Clin Lab Invest; 1977 Feb; 37(1):15-20. PubMed ID: 616022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone oral contraception and blood coagulation.
    Poller L; Thomson JM; Tabiowo A; Priest CM
    Br Med J; 1969 Mar; 1(5643):554-6. PubMed ID: 4179339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.